BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 37958689)

  • 1. From the Skin to Distant Sites: T Cells in Psoriatic Disease.
    Reali E; Ferrari D
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cell responses in psoriasis and psoriatic arthritis.
    Diani M; Altomare G; Reali E
    Autoimmun Rev; 2015 Apr; 14(4):286-92. PubMed ID: 25445403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psoriatic disease--from skin to bone.
    Ritchlin C
    Nat Clin Pract Rheumatol; 2007 Dec; 3(12):698-706. PubMed ID: 18037929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psoriatic arthritis: a clinical entity distinct from psoriasis?
    Ruiz DG; Azevedo MN; Santos OL
    Rev Bras Reumatol; 2012 Aug; 52(4):630-8. PubMed ID: 22885427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psoriasis and psoriatic arthritis: clinical features and disease mechanisms.
    Myers WA; Gottlieb AB; Mease P
    Clin Dermatol; 2006; 24(5):438-47. PubMed ID: 16966023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nailing down the genetic and immunological basis for psoriatic disease.
    McGonagle D; Palmou Fontana N; Tan AL; Benjamin M
    Dermatology; 2010; 221 Suppl 1():15-22. PubMed ID: 20733311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kv1.3 in psoriatic disease: PAP-1, a small molecule inhibitor of Kv1.3 is effective in the SCID mouse psoriasis--xenograft model.
    Kundu-Raychaudhuri S; Chen YJ; Wulff H; Raychaudhuri SP
    J Autoimmun; 2014 Dec; 55():63-72. PubMed ID: 25175978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Microbiome in Psoriasis and Psoriatic Arthritis: The Skin Perspective.
    Thio HB
    J Rheumatol Suppl; 2018 Jun; 94():30-31. PubMed ID: 29858350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cutting edge overview: psoriatic disease.
    Raychaudhuri SP
    Clin Rev Allergy Immunol; 2013 Apr; 44(2):109-13. PubMed ID: 22359072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCR4
    Montico G; Mingozzi F; Casciano F; Protti G; Gornati L; Marzola E; Banfi G; Guerrini R; Secchiero P; Volinia S; Granucci F; Reali E
    Eur J Immunol; 2023 Apr; 53(4):e2149702. PubMed ID: 36722608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pivotal Role of mTOR in Non-Skin Manifestations of Psoriasis.
    Joo K; Karsulovic C; Sore M; Hojman L
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of the molecular determinants contributing to the expression of Psoriasis and Psoriatic Arthritis phenotypes.
    Caputo V; Strafella C; Termine A; Dattola A; Mazzilli S; Lanna C; Cosio T; Campione E; Novelli G; Giardina E; Cascella R
    J Cell Mol Med; 2020 Dec; 24(23):13554-13563. PubMed ID: 33128843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Use of Microbial Modifying Therapies to Prevent Psoriasis Exacerbation and Associated Cardiovascular Comorbidity.
    Reali E; Caliceti C; Lorenzini A; Rizzo P
    Inflammation; 2024 Feb; 47(1):13-29. PubMed ID: 37953417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic inflammation in asocial BTBR T
    Nadeem A; Ahmad SF; El-Sherbeeny AM; Al-Harbi NO; Bakheet SA; Attia SM
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Apr; 83():8-17. PubMed ID: 29287831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA methylation patterns in CD4
    Natoli V; Charras A; Hofmann SR; Northey S; Russ S; Schulze F; McCann L; Abraham S; Hedrich CM
    Front Immunol; 2023; 14():1245876. PubMed ID: 37662940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine alterations in psoriasis: an updated review.
    Seyedmirzaei H; Rezaei N
    Expert Rev Clin Immunol; 2021 Dec; 17(12):1323-1335. PubMed ID: 34845948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infiltration of T Cells into a Three-Dimensional Psoriatic Skin Model Mimics Pathological Key Features.
    Lorthois I; Simard M; Morin S; Pouliot R
    Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30987186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Innate Lymphocytes in Psoriasis.
    Polese B; Zhang H; Thurairajah B; King IL
    Front Immunol; 2020; 11():242. PubMed ID: 32153574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psoriasis and psoriatic arthritis: immunological aspects and therapeutic guidelines.
    Griffiths CE; Iaccarino L; Naldi L; Olivieri I; Pipitone N; Salvarani C; Doria A
    Clin Exp Rheumatol; 2006; 24(1 Suppl 40):S72-8. PubMed ID: 16466629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response of murine and normal human skin to injection of allogeneic blood-derived psoriatic immunocytes: detection of T cells expressing receptors typically present on natural killer cells, including CD94, CD158, and CD161.
    Nickoloff BJ; Wrone-Smith T; Bonish B; Porcelli SA
    Arch Dermatol; 1999 May; 135(5):546-52. PubMed ID: 10328195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.